EXCLUSIVE: Meet the Company Developing Graphene-Based Healthcare Solutions

Image provided by Unsplash

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.

Greg Fenton, CEO of Zentek Ltd. (TSXV:ZEN) (OTCPK: ZENYF) was a speaker at Benzinga’s Small Cap Conference in October.

Zentek is an IP development and commercialization company focused on next-generation, nanotechnology-enabled healthcare solutions.

Fenton discusses ZEN’s numerous intellectual property (IP) developments and ongoing commercialization opportunities.

Watch the full presentation:

The preceding post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Although the piece is not and should not be construed as editorial content, the sponsored content team works to ensure that any and all information contained within is true and accurate to the best of their knowledge and research. This content is for informational purposes only and not intended to be investing advice.

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.